| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |